A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer
Clinical trial NCT02507544 · COMPLETED
Trial details
- NCT number
- NCT02507544
- Sponsor
- TaiRx, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-04-29
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.